Barclays Increases AbbVie (NYSE:ABBV) Price Target to $185.00
AbbVie (NYSE:ABBV – Free Report) had its price objective increased by Barclays from $175.00 to $185.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the stock. A number of other equities research analysts have also recently commented on ABBV. UBS Group cut their price […]
More Stories
Datametrex AI (CVE:DM) Trading Down 50% – What’s Next?
Datametrex AI Limited (CVE:DM – Get Free Report)’s stock price dropped 50% on Saturday . The company traded as low...
OPG Power Ventures (LON:OPG) Stock Price Up 12.6% – What’s Next?
OPG Power Ventures Plc (LON:OPG – Get Free Report)’s stock price rose 12.6% during mid-day trading on Saturday . The...
Durango Resources (CVE:DGO) Trading Up 28.6% – Should You Buy?
Durango Resources Inc. (CVE:DGO – Get Free Report) shot up 28.6% during mid-day trading on Saturday . The company traded...
Simplify Intermediate Term Treasury Futures Strategy ETF (TYA) to Issue Dividend of $0.07 on December 31st
Simplify Intermediate Term Treasury Futures Strategy ETF (BATS:TYA – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends...
Invesco Short Duration Bond ETF (ISDB) to Issue Dividend of $0.12 on December 27th
Invesco Short Duration Bond ETF (BATS:ISDB – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports. Stockholders...
Simplify NEXT Intangible Core Index ETF (NXTI) To Go Ex-Dividend on December 23rd
Simplify NEXT Intangible Core Index ETF (BATS:NXTI – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports....